Use of protein psa3 as a marker for colorectal cancer

Details Use of protein psa3 as a marker for colorectal cancer Use of protein psa3 as a marker for colorectal cancer

G - Physics

01

N

G01N 33/574 (2006.01)

Patent

CA 2531191

The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein proteasome subunit alpha 3 (PSA3) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring PSA3 in said sample. Measurement of PSA3 can, e.g., be used in the early detection or diagnosis of colorectal cancer.

La présente invention concerne le diagnostic du cancer colorectal au moyen de la protéine PSA (sous-unité 3 de protéine activatrice de protéasome). La protéine PSA3 est mesurée dans un échantillon liquide prélevé sur un individu. Cette mesure permet de détecter ou de diagnostiquer précocement un cancer colorectal.

Affiliated with

Also associated with

Rating

Use of protein psa3 as a marker for colorectal cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of protein psa3 as a marker for colorectal cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of protein psa3 as a marker for colorectal cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1431575